| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 02/11/1998 | EP0822982A1 Cyclomaltodextrin glucanotransferase variants |
| 02/11/1998 | EP0822981A1 Enzymatic production of halogenated cephalosporin |
| 02/11/1998 | EP0667909B1 Biotechnological method of producing biotin |
| 02/11/1998 | CN1173206A Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus |
| 02/11/1998 | CN1173205A Municipal solid waste processing facility and commercial lactic acid production process |
| 02/11/1998 | CN1173180A Substance Mk7634, process for production thereof, and anthelminthic containing said substance |
| 02/11/1998 | CN1172785A Carbon dioxide gas fertilizer and its production method |
| 02/11/1998 | CN1172653A Rhodospirillum preparation and its preparing method and application |
| 02/10/1998 | US5717074 Macrophage-derived inflammatory mediator (MIP-2) |
| 02/10/1998 | US5716839 Applying cedar pieces, nitrogen and phosphorous nutrients to promot biodegradation of hydrocarbons |
| 02/10/1998 | US5716838 Culture of microorganisms such as rhizobium, arthrobacter |
| 02/10/1998 | US5716820 Fumonisin detoxification enzymes |
| 02/10/1998 | US5716819 Genetic engineering |
| 02/10/1998 | US5716810 Nucleic acid encoding the mature βB chain of inhibin and method for synthesizing polypeptides using such nucleic acid |
| 02/10/1998 | US5716803 Recombinant protein production with reduced expression of selectable markers |
| 02/10/1998 | US5716654 Homogeneous mixture comprising a baking promoter coated on as a film or adhered particles; shelf life, storage stability |
| 02/10/1998 | US5716620 Vaccines, diagnostic immunoassay |
| 02/05/1998 | WO1998004736A1 Mutant urease and method of use for determination of urea |
| 02/05/1998 | WO1998004733A1 Production of amino acids and enzymes used therefor |
| 02/05/1998 | WO1998004730A1 Methods for isolating nucleic acids using alkaline protease |
| 02/05/1998 | WO1998004726A1 Hsv strain lacking functional icp27 and icp34.5 genes |
| 02/05/1998 | WO1998004722A1 Invertase inhibitor |
| 02/05/1998 | WO1998004721A1 BIOSYNTHETIC GENE ddl FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 02/05/1998 | WO1998004718A1 Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 02/05/1998 | WO1998004715A1 Novel strains of escherichia coli, methods of preparing the same and use thereof in fermentation processes for l-threonine production |
| 02/05/1998 | WO1998004714A1 A NOVEL HUMAN mRNA EDITING ENZYME |
| 02/05/1998 | WO1998004711A2 Desaturase antigen of mycobacterium tuberculosis |
| 02/05/1998 | WO1998004703A1 THE NucA PROTEIN OF HAEMOPHILUS INFLUENZAE AND THE GENE ENCODING THAT PROTEIN |
| 02/05/1998 | WO1998004701A1 Methods and compositions for improving a plant's ability to take in phosphate from soil |
| 02/05/1998 | WO1998004694A2 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1998004692A2 Human neuronatin |
| 02/05/1998 | WO1998004691A1 Human proteolipid |
| 02/05/1998 | WO1998004690A1 Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof |
| 02/05/1998 | WO1998004688A1 Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons |
| 02/05/1998 | WO1998004685A1 Hppd gene and inhibitors |
| 02/05/1998 | WO1998004679A1 Process for the biodegradation of aromatic compounds and synthesis of pigments and colorants, alcaloids and polymers, with the use of the recombinant strain escherichia coli p260 |
| 02/05/1998 | WO1998004678A2 Micro-organism which can desulphurise benzothiophenes |
| 02/05/1998 | WO1998004677A1 Methods for fractionation of biologically-derived materials |
| 02/05/1998 | WO1998004674A1 METHOD AND MEDIUM FOR DETECTING VANCOMYCIN-RESISTANT $i(ENTEROCOCCUS) |
| 02/05/1998 | WO1998004585A2 Novel human macrophage antigen |
| 02/05/1998 | WO1998004576A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/05/1998 | WO1998004503A1 Biological treatment of spent caustics |
| 02/05/1998 | WO1998004300A1 Use of microorganisms for processing bioprosthetic tissue |
| 02/05/1998 | WO1998004288A1 Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof |
| 02/05/1998 | WO1997047744A3 T-cell selective interleukin-4 agonists |
| 02/05/1998 | WO1997043423A3 Alpha-glucuronidases of aspergillus, production thereof and their uses |
| 02/05/1998 | WO1997040069A3 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1997039623A3 Improved production of insecticidal proteins |
| 02/05/1998 | CA2262478A1 Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof |
| 02/05/1998 | CA2262412A1 Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof |
| 02/05/1998 | CA2262016A1 Production of amino acids and enzymes used therefor |
| 02/05/1998 | CA2262002A1 Hppd gene and inhibitors |
| 02/05/1998 | CA2261882A1 Biological treatment of spent caustics |
| 02/05/1998 | CA2261823A1 Desaturase antigen of mycobacterium tuberculosis |
| 02/05/1998 | CA2261581A1 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | CA2261575A1 Novel human macrophage antigen |
| 02/05/1998 | CA2261563A1 Human proteolipid |
| 02/05/1998 | CA2261164A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/05/1998 | CA2261155A1 Biosynthetic gene ddl from streptococcus pneumoniae |
| 02/05/1998 | CA2260740A1 A novel human mrna editing enzyme |
| 02/05/1998 | CA2232975A1 The nuca protein of haemophilus influenzae and the gene encoding that protein |
| 02/04/1998 | EP0822253A2 Novel microbial strain, method for biodegrading organic compounds and method for environmental remediation |
| 02/04/1998 | EP0822252A2 Microbial strains, method for biodegrading organic compounds and method for environmental remediation |
| 02/04/1998 | EP0821982A2 High-Temperature Desulfurization by Microorganisms |
| 02/04/1998 | EP0821736A1 Bacteriocins |
| 02/04/1998 | EP0821734A2 Use of an "immunodeficiency-virus suppressing lymphokine (isl)" to inhibit the replication of viruses, in particular of retroviruses |
| 02/04/1998 | EP0821732A1 Altered polypeptides with increased half-life |
| 02/04/1998 | EP0821729A1 Structure-based designed herbicide resistant products |
| 02/04/1998 | EP0821728A1 Tie-2 ligands, methods of making and uses thereof |
| 02/04/1998 | EP0821698A1 Protective helicobacter antigens |
| 02/04/1998 | EP0760848B1 Lactobacillus strains of human origin, their compositions and uses thereof |
| 02/04/1998 | EP0651800B1 Basophil granule proteins |
| 02/04/1998 | EP0383837B1 Alveolar surfactant proteins |
| 02/04/1998 | CN1172511A Method and compositions for treating cellulose containing fabrics using truncated cellulase enzyme compositions |
| 02/04/1998 | CN1172503A Toxins from wasp bracon hebetor |
| 02/04/1998 | CN1172502A In vivo mutations and polymorphisms in 17 q -linked breast and ovarian cancer susceptibility gene |
| 02/04/1998 | CN1172501A Method for disigning alpha-amylase mutants with predetermined properties |
| 02/04/1998 | CN1172500A Amylase variants |
| 02/04/1998 | CN1172165A Fermentative production of d- biotin |
| 02/04/1998 | CN1172160A Usage of wild fungi and culturing method thereof |
| 02/03/1998 | US5714595 Mechanism-based screen for retinoid X receptor agonists and antagonists |
| 02/03/1998 | US5714594 cDNA cloning and expression of human liver estrogen sulfotransferase |
| 02/03/1998 | US5714593 Vaccines, medical diagnosis |
| 02/03/1998 | US5714382 Isolated dna encoding feline interferon precursor having specified amino acid sequence |
| 02/03/1998 | US5714378 Pseudomonas chlororaphis microorganism polyurethane degrading enzyme obtained therefrom and method of using enzyme |
| 02/03/1998 | US5714377 Modified fungal cells and method for producing recombinant products |
| 02/03/1998 | US5714376 For products with specific anticoagulant activity |
| 02/03/1998 | US5714375 Ileal symbiont intracellularis propagation in suspended host cells |
| 02/03/1998 | US5714364 Phenylalanine dehydrogenase production |
| 02/03/1998 | US5714362 Human superoxide dismutase cDNA |
| 02/03/1998 | US5714355 Biologically pure culture of mutant microorganism |
| 02/03/1998 | US5714352 Genetic engineering |
| 02/03/1998 | US5714349 Cultivating escherichia coli transformed with plasmid under conditions suitable for expression of human parathyroid hormone |
| 02/03/1998 | US5714348 Culturing, supplying glycerol to inoculated fermentation broth at a rate proportional to oxygen uptake rate of microorganism until a threshold value is reached, then providing glycerol to broth at constant supply until finish |
| 02/03/1998 | US5714346 Process for production of human growth hormone using Bacillus Brevis |
| 02/03/1998 | US5714334 Gene and method for production of an IgA binding protein |
| 02/03/1998 | US5714313 Simple method for detecting inhibitors of retroviral replication |
| 02/03/1998 | US5714152 Herpes simplex virus VP16 vaccines |
| 01/29/1998 | WO1998003671A1 Process for preparing docosahexaenoic acid and docosapentaenoic acid |
| 01/29/1998 | WO1998003670A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |